跳至主要内容
临床试验/CTRI/2011/11/002150
CTRI/2011/11/002150招募中未知

Evaluation of the role of Doxycycline in Interstitial Lung Disease (ILD) /Diffuse Parenchymal Lung Disease (DPLD) in a real world observation

Institute of Pulmocare Research0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Willing to give written informed consent
  • 2. Clinically suspected patients with ILDs with the diagnosis being substantiated through chest X-ray(PA) and HRCT chest.

排除标准

  • 1.History of exacerbation in past 1 month
  • 2.History of Doxy allergy
  • 3.Having any obvious contraindication for Doxycycline
  • 4.Unable to meet the demand of the protocol for any reason
  • 5.Significant abnormality in liver or renal function
  • 6. Feature of chronic congestive cardiac failure (supported by echocardiography)
  • 7.Known case of Idiopathic pulmonary disease with cardiovascular disease

研究者

相似试验

Treating shrinking of lungs | 临床试验